Cryo-Cell Debt to Equity Ratio 2010-2025 | CCEL
Current and historical debt to equity ratio values for Cryo-Cell (CCEL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cryo-Cell debt/equity for the three months ending February 28, 2025 was 0.00.
| Cryo-Cell Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-02-28 | $0.08B | $-0.02B | -5.39 |
| 2024-11-30 | $0.08B | $-0.01B | -5.89 |
| 2024-08-31 | $0.07B | $-0.01B | -7.58 |
| 2024-05-31 | $0.07B | $-0.01B | -6.83 |
| 2024-02-29 | $0.07B | $-0.01B | -6.97 |
| 2023-11-30 | $0.07B | $-0.01B | -6.55 |
| 2023-08-31 | $0.07B | $0.00B | -4309.41 |
| 2023-05-31 | $0.07B | $0.00B | -81.10 |
| 2023-02-28 | $0.07B | $0.00B | -97.20 |
| 2022-11-30 | $0.07B | $0.00B | -43.57 |
| 2022-08-31 | $0.07B | $0.00B | -28.99 |
| 2022-05-31 | $0.05B | $0.00B | 11.57 |
| 2022-02-28 | $0.05B | $0.00B | 11.89 |
| 2021-11-30 | $0.06B | $0.00B | 13.50 |
| 2021-08-31 | $0.06B | $0.01B | 11.38 |
| 2021-05-31 | $0.05B | $0.00B | 13.57 |
| 2021-02-28 | $0.11B | $0.00B | -63.10 |
| 2020-11-30 | $0.05B | $0.00B | -18.34 |
| 2020-08-31 | $0.05B | $0.00B | -12.01 |
| 2020-05-31 | $0.05B | $-0.01B | -10.00 |
| 2020-02-29 | $0.05B | $-0.01B | -8.45 |
| 2019-11-30 | $0.05B | $-0.01B | -7.17 |
| 2019-08-31 | $0.05B | $-0.01B | -7.01 |
| 2019-05-31 | $0.05B | $-0.01B | -6.05 |
| 2019-02-28 | $0.05B | $-0.01B | -6.26 |
| 2018-11-30 | $0.05B | $-0.01B | -5.76 |
| 2018-08-31 | $0.05B | $-0.01B | -5.33 |
| 2018-05-31 | $0.04B | $-0.01B | -2.58 |
| 2018-02-28 | $0.04B | $-0.01B | -2.53 |
| 2017-11-30 | $0.04B | $-0.01B | -2.91 |
| 2017-08-31 | $0.04B | $-0.01B | -2.59 |
| 2017-05-31 | $0.04B | $-0.01B | -2.47 |
| 2017-02-28 | $0.04B | $-0.02B | -2.33 |
| 2016-11-30 | $0.04B | $-0.02B | -2.27 |
| 2016-08-31 | $0.04B | $-0.02B | -2.03 |
| 2016-05-31 | $0.03B | $-0.01B | -5.45 |
| 2016-02-29 | $0.02B | $-0.01B | -4.58 |
| 2015-11-30 | $0.02B | $-0.01B | -4.93 |
| 2015-08-31 | $0.02B | $-0.01B | -5.03 |
| 2015-05-31 | $0.02B | $-0.01B | -2.02 |
| 2015-02-28 | $0.02B | $-0.01B | -2.02 |
| 2014-11-30 | $0.02B | $-0.01B | -1.95 |
| 2014-08-31 | $0.02B | $-0.01B | -1.99 |
| 2014-05-31 | $0.02B | $-0.01B | -2.06 |
| 2014-02-28 | $0.02B | $-0.01B | -2.15 |
| 2013-11-30 | $0.02B | $-0.01B | -2.24 |
| 2013-08-31 | $0.02B | $-0.01B | -2.25 |
| 2013-05-31 | $0.02B | $-0.01B | -2.27 |
| 2013-02-28 | $0.02B | $-0.01B | -2.37 |
| 2012-11-30 | $0.02B | $-0.01B | -2.37 |
| 2012-08-31 | $0.02B | $-0.01B | -2.55 |
| 2012-05-31 | $0.02B | $-0.01B | -2.71 |
| 2012-02-29 | $0.02B | $-0.01B | -4.59 |
| 2011-11-30 | $0.02B | $0.00B | -8.91 |
| 2011-08-31 | $0.02B | $0.00B | -8.81 |
| 2011-05-31 | $0.02B | $0.00B | -53.71 |
| 2011-02-28 | $0.02B | $0.00B | -31.63 |
| 2010-11-30 | $0.02B | $0.00B | -19.06 |
| 2010-08-31 | $0.02B | $0.00B | -9.85 |
| 2010-05-31 | $0.02B | $0.00B | -4.44 |
| 2010-02-28 | $0.02B | $-0.01B | -4.03 |
| 2009-11-30 | $0.02B | $-0.01B | -3.82 |
| 2009-08-31 | $0.02B | $-0.01B | -3.73 |
| 2009-05-31 | $0.02B | $-0.01B | -3.27 |
| 2009-02-28 | $0.02B | $-0.01B | -2.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.047B | $0.032B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| Natera (NTRA) | United States | $20.018B | 0.00 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| Revvity (RVTY) | United States | $11.032B | 18.74 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Doximity (DOCS) | United States | $9.934B | 51.66 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| HealthEquity (HQY) | United States | $7.311B | 35.97 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |